Clinical Trial Update: Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of gemtuzumab ozogamicin in adults with intermediate-risk acute myeloid leukemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: Nantes University Hospital | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED